Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 Sep 10.
Published in final edited form as: Pediatr Clin North Am. 2006 Oct;53(5):1029–xi. doi: 10.1016/j.pcl.2006.08.003

Reactive Oxygen Species Cerebral Autoregulation in Health and Disease

Maia Terashvili 1, Phillip F Pratt 2, Debebe Gebremedhin 1, Jayashree Narayanan 1, David R Harder 1
PMCID: PMC2533262  NIHMSID: NIHMS60573  PMID: 17027622

Abstract

Superoxide and other oxygen radicals (ROS) derived from the oxidative metabolism of L-arginine influence cell signaling and gene expression. In some tissue ROS stimulate structural changes, such as proliferation, hypertrophy, or remodeling. ROS production within the developing CNS stimulates excitation and in vascular tissue causes contraction. The effect of ROS-induced autoregulatory failure in the CNS following hypoxic-ischemic encephalopathy, seizures, trauma, or stroke in children leads to acute mortality and chronic morbidity.

Production and effects of ROS on the cerebral vasculature

Regulation of nutritive blood flow to metabolically active tissue is a vital process supplying substrate for enzymatic production of intermediates to maintain cellular homeostasis. In the brain, neuronal metabolism relies almost exclusively on oxidative pathways requiring adequate delivery of oxygen and glucose. Under normal ranges of physiological blood pressure, cerebral blood flow to the brain remains constant despite fluctuations in transmural pressure. This autoregulation is largely a function of signaling events in the vessel wall such that increasing arterial pressure depolarizes and activates arterial muscle keeping flow relatively constant (14).

Reactive oxygen species are believed to be involved in cellular signaling in blood vessels in both normal and pathological states. The major pathway for the production of ROS is by way of the one-electron reduction of molecular oxygen to form an oxygen radical, the superoxide anion (O2.−). Within the vasculature, there are several enzymatic sources of O2.−, including xanthine oxidase, the mitochondrial electron transport chain, and nitric oxide (NO) synthases (5). Studies in recent years, however, suggest that the major contributor to O2.− levels in vascular cells is the membrane-bound enzyme NADPH-oxidase (6). Produced O2.− can react with other radicals, such as NO, or spontaneously dismutate to produce hydrogen peroxide (H2O2) (7). In cells, the latter reaction is an important pathway for normal O2.− breakdown and is usually catalyzed by the enzyme superoxide dismutase (SOD). Once formed, H2O2 can undergo various reactions, both enzymatic and non-enzymatic. The anti-oxidant enzymes catalase and glutathione peroxidase act to limit ROS accumulation within cells by breaking down H2O2 to H2O. Metabolism of H2O2 can also produce other, more damaging ROS (8). For example, the endogenous enzyme myeloperoxidase uses H2O2 as a substrate to form the highly reactive compound hypochlorous acid. Alternatively, H2O2 can undergo Fenton or Haber-Weiss chemistry, reacting with Fe2+/Fe3+ ions to form toxic hydroxyl radicals (−.OH) (8).

ROS are involved in oxidation of lipoproteins, modulation of apoptosis, upregulation of adhesion molecule expression, and activation of the processes involved in vascular remodeling, such as enhancement of vascular smooth muscle growth and activation of matrix metalloproteinases (9). In addition, one of the most powerful acute effects of ROS in the vasculature is the alteration of vascular smooth muscle tone. There is evidence that O2.− can not only constrict (10), but can also dilate cerebral arteries (11). Moreover, several studies have demonstrated clearly that small cerebral arterioles relax in response to the O2.− metabolite H2O2 (12,13). H2O2 thus causes powerful dilatation of cerebral arterioles whether applied exogenously or generated endogenously within the vascular wall in response to agonist, such as bradykinin or arachidonic acid (14,15). These dilator responses seem to be mediated primarily by cyclooxygenase-derived ROS, which open potassium channels in the vascular smooth muscle cell membrane to cause hyperpolarization and thus relaxation (1416). In the cerebral circulation, therefore, ROS such as O2.− and H2O2 could possibly either dilate or even exert opposing effects on vascular tone. The balance between O2.− and H2O2 in the vascular wall is regulated by the expression and activity of endogenous SOD.

The role of cytochrome P450 enzymes for the production of ROS

The cytochrome P450 (CYP) enzymes are membrane-bound, heme-containing terminal oxidases that are bound in organism from Archaebacteria to humans. These enzymes are responsible for the metabolic activation or inactivation of most type of drugs and toxins. CYP enzymes are capable of metabolizing endogenous arachidonic acid (AA) into vasoreactive products and are therefore are often referred to as the third pathway of AA metabolism (cyclooxygenases and lipooxygenases being the other two pathways). Much attention thus have been focused on the role of CYP enzymes in vascular homeostasis (17). In addition to the production of vasoreactive AA metabolites, CYP enzymes also generate ROS, such as O2.−, H2O2. For example, released free AA following stimulation of astrocytes with glutamate is converted to epoxyeicosatrienoic acid (EETs) by microsomal epoxygenases (CYP 2C11) or PGI2/Tx by cyclooxygenases. Both these processes generate O2.−, which is further metabolized to H2O2 by superoxide dismutase (SOD). Similarly, stimulation of vascular smooth muscle cell by pressure, stretch, flow and so forth, triggers the release of AA, which is metabolized to 20-HETE by CYP 4A enzyme that can also generate O2.−, which is further metabolized to H2O2 by SOD. ROS thus are produced during metabolism of AA by CYP enzymes and may play an important role in regulation of the tyrosine kinase pathways. Additionally, another recent report provides strong evidence that O2.− participates in the endothelium-derived hyperpolarizing factor (EDHF) response of CYP-derived EETs, suggesting that an endothelial epoxygenase homologous to human CYP 2C8/9 is the source of O2.− in coronary arteries (17). Release of inhibitory radical species would be expected to inhibit pressure-induced myogenic tone. On the other hand, O2.− has been shown to inhibit NO production, which would enhance myogenic tone (18). Given the potential sources of ROS formation in the form of NADPH P450 oxidases in the cerebral arterial wall, it is important that we define the role of ROS on myogenic mechanisms in the cerebral circulation.

Action of ROS on ion channels

Maintenance of cellular ionic gradient is essential to cell survival and function. Apart from maintaining osmotic equilibrium, ion channels are co-transporters that mediate the movement of ions against electrical and concentration gradients and regulate plasma and mitochondrial membrane potential. Plasma membrane potential controls many cell-specific processes. In the brain, the membrane potential controls the active state of arterial muscle, release of paracrine substances from vascular and capillary endothelial cells, neuronal activity, and multiple processes in astrosytes. With respect to arteriolar muscle there are four major K+ channel isoforms: Ca2+-activated K+ channels, delayed rectifier K+ channels, inwardly rectifying K+ channels, and ATP-sensitive K+ channels (19). Upon patch clamping freshly isolated cerebral arteriolar muscle the major K+ channel isoform present is KCa. If analogy with other excitable cells is assumed, it is the inwardly rectifying K+ channel that is largely responsible for setting the level of membrane potential (19, 20). Inhibition of K+ channels depolarizes cerebral vascular muscle as defined by the K+ equilibrium potential, however (21, 22). The major voltage sensitive Ca2+ channel in cerebral arterial muscle is the L-type Ca2+ channel (23). To date we have very little evidence for rapidly inactivating T-type Ca2+ channels in cerebral arterial muscle. There are also several Cl channels in cerebral arteriolar muscle, and there is increased interest in them with respect to regulation of membrane potential and other cellular processes (24). In this review wefocus on KCa channel.

Free radicals exert direct and indirect actions on ion channels. The redox status of channel proteins has been hypothesized to affect the ion channel activity in arterial muscle (25, 26). This hypothesis states that the balance between oxygen and its reactive species functions as an oxygen sensor through actions on ion channels (26, 27). In this regard K+ channels have been shown to be sensitive to H2O2 (26, 2831). H2O2 has been demonstrated to hyperpolarize arterial muscle by way of activation of maxi KCa by direct and indirect mechanisms (15, 26, 2831). In cat, H2O2 has been shown to activate ATP sensitive K+ channels (11). A recent report provides evidence that H2O2 can function as an EDHF (31). ROS repeatedly have been demonstrated to modulate [Ca2+]i on agonist stimulation of L-type Ca2+ channels, which could be either the primary or secondary target (32). The literature on free radicals and direct action on ion channels as determined by patch clamp or direct measurement of membrane potential is not extensive. Given the importance of membrane potential on cellular control mechanisms, however, this is an area of active investigation.

There are many indirect actions of ROS on vascular membrane potential. Activation/inhibition of ion channels to a large extent depends on channel protein phosphorylation. Both upstream regulators of protein/tyrosine kinases and direct effects on their translocation and activation have been shown to be sensitive to reactive radical species. Tyrosine kinases and phosphatases are targets of H2O2 as activators and inhibitors (33). H2O2 can activate ERK1/2 and p38 MAPK in the presence of agents such as angiotensin (9, 34). H2O2 also can mediate EGF-induced activation of phospholipase C (PLC) (35). In general, phospholipases are targets of ROS. PLC activity regulates diacilglycerol (DAG) levels, which in turn activates and induces translocation of protein kinase C (PKC) (36). Recent literature demonstrates that ion channel phosphorylation is mediated by kinase activity (37, 38). Alteration of PKC, either through DAG or directly, and tyrosine kinase activities induced by ROS would be expected to modulate ion channel activity, resulting in membrane potential responses with downstream modulation of cell functions under membrane potential influence. Similarly, modification of PLC activity changes levels of intracellular inositol triphosphate (IP3) affecting Ca2+ release from internal stores.

Action of ROS on KCa channel activity in cerebral arterial muscle cells

Activation of arterial smooth muscle is regulated by the level of membrane potential. The plasma membrane potential is set by unequal distribution of ions. Ion species with high relative conductance set the membrane potential in accordance to specific charge and concentration gradients (ie, Nernst potential); in vascular muscle cells K+ is the dominant species in this regard. Vascular smooth muscle membrane potential is a major influence in defining the level of activation, and in cerebral arterial muscle cells the major determinant of activation and contraction. Indeed, a 1.0 mV reduction in membrane potential initiates a significant increase in active tension with a correlation coefficient relating change in membrane potential to change in active tension of 0.98 (2,3). The mechanisms by which ROS modulate ion channels, including KCa channel activity in vascular muscle remain largely unexplored. We have shown that the KCa is a target for O2.− (39). At this time we do not know how O2.− enhance KCa activity; it could act directly on channel proteins or on second messengers, which include PKC and tyrosine kinase, that mediate phosphorylation of KCa channels. Generation of H2O2 also seems to activate KCa (Debebe Gebremedhin, PhD, and David R. Harder, PhD, unpublished data, 2005). Both H2O2 and O2.− thus act to increase single-channel KCa activity in cerebral vascular muscle cells.

ROS in the brain: actions on functional hyperemia

The source of ROS in the brain may require CYP enzyme activity and is supported further by data obtained recently in our laboratory using samples of cerebrospinal fluid (CSF) containing the spin trap N-tert-butyl-hydroxylamine, which is selective for O2.− (Debebe Gebremedhin, PhD, and David R. Harder, PhD, unpublished data, 2005) and support a recent report that an endothelial CYP isoform (C8/C9) generate O2.− in coronary arteries (40). Given the many cell type in the brain, it is certain that there is no single source of ROS. Whatever the sources of ROS, these free radicals appear to impinge chronically on mechanisms regulating blood flow in the brain; For example, infusion of scavengers, such as SOD, into the CSF increased blood flow as measured by laser-Doppler flowmetry (Debebe Gebremedhin, PhD, and David R. Harder, PhD, unpublished data, 2005)). The effect of SOD on baseline blood flow is most likely attributed to removal of O2.−, which potentially enhances nitric oxide. The increase in blood flow was reversed after the infusion was completed (Debebe Gebremedhin, PhD, and David R. Harder, PhD, unpublished data, 2005). The literature would suggest that the source of cerebral O2.− produced would be by way of nitric oxide synthase (NOS) through NAD(P)H dependent reductase activity. The CYP NAD(P)H reductase, however, is virtually the same as NOS (NOS is a heme containing protein similar to CYP enzyme system). In summary, scavenging of O2.− by infusion of SOD modulates the cerebral blood flow in vivo (Debebe Gebremedhin, PhD, and David R. Harder, PhD, unpublished data, 2005), demonstrating that these molecules participate in the regulation of nutritive blood flow in the brain. Even more dramatic is the action of 30 minute subdural infusion of a cocktail of xanthine/xanthine oxidase/catalase (X/XO/Cat, 0.2 mM xanthine/20 mU xanthine oxidase/500 U catalase). We have shown that under control conditions there is significant autoregulation of CSF; however, there is complete inhibition of CSF autoregulation on elevation of arterial pressure following infusion of a cocktail designed to generate excess O2.− as shown by increased fluorescent intensity of ethidium bromide produced by O2.− from dihydroethidium (39).

When a membrane-enriched homogenate is exposed to H2O2 (xanthine/XO) there is a marked and significant reduction in 20-HETE formation by way of CYP ω-hydroxylase (Debebe Gebremedhin, PhD, and David R. Harder, PhD, unpublished data, 2005), which is one of the primary mediators of pressure-induced activation of cerebral arteries (41, 42). The action of O2.− in inhibiting 20-HETE production in a membrane-enriched solution in which all conditions are optimized is most likely attributable to a direct action on CYP ω-hydroxylase activity.

Possible pathogenetic role of intracisternally generated ROS

Subarachnoid hemorrhage (SAH) results in a high mortality rate; 15% of patients who have SAH die before reaching the hospital and 30 % die within 24 hours of onset (43). Patients who survive the initial hemorrhage and overcome vasospasms frequently experience persistent cognitive deficits, psychosocial impairments, and a decrease in quality of life as a result of acute brain injury (44). Most of the research has focused on the late phase, however, when vasospasm occurs, whereas the mechanisms of acute brain injury are poorly understood.

Lipid peroxidation and other consequences of increased levels of ROS have been implicated in the cause of cerebral vasospasm after SAH (45, 46). The primary contributor to ROS production after SAH is the autooxidation within the subarachnoid space of oxyhemoglobinto met-Hb (47). As a direct product of this redox reaction, O2.− is converted to highly reactive hydroxide anion (−.OH) through the metal-catalyzed Haber-Weiss and Fenton reactions (48,49). In support of this theory that ROS are primary pathogens for SAH, various antioxidants have been shown to attenuate cerebral vasospasm in animals and humans (5054). It also has been shown that intracisternal overproduction of O2.− may initiate or mediate cerebral arterial vasoconstriction and subsequent structural damage (46). Moreover, administration of ferrous (Fe2+) or ferric (Fe3+) iron chelators was shown to mitigate against cerebral vasospasm, providing evidence that the iron-catalyzed Haber-Weiss and Fenton reactions are involved in the mechanism of ROS generation leading to the occurrence of cerebral vasospasm (55,56). These studies further support the pathogenic role of ROS in cerebral vasospasm after SAH.

In summary, cerebral blood flow is maintained at a constant rate despite fluctuations in arterial pressure. The ability of the cerebral vasculature to autoregulate is primarily the function of the activities of native KCa channel. The KCa channel is also a target for several paracrine factors and various physical forces, which alter cerebral tone. Astrocytes are intermediary cell types that function to increase cerebral blood flow to match the metabolic demand of activated neurons. Channelophathy coupled with functional alteration of the mechanisms regulating cerebral blood flow could lead to stroke or cerebral vasospasm. Knowledge of the mechanism by which the functions of the cerebral circulation are regulated will help to develop new therapies for the treatment of pediatric patients suffering from hypoxic injury, trauma, stroke and other cerebral disorders, including acute infections such as meningitis and encephalitis (57).

Acknowledgments

We gratefully acknowledge the following grants PO1 HL6876, PO1 HL59996, RO1 HL33833 supported by the NIH/NHLBI and the Veterans administration grant 3440-06P.

Footnotes

Maia Terashvili, PhD, Phone: 414-456-5723, E-mail: mterashv@mcw.edu

Phillip F. Pratt, PhD, Phone: 414-456-5644, E-mail: ppratt@mcw.edu

Debebe Gebremedhin, PhD, Phone: 414-456-5715, E-mail: mariyei@mcw.edu

Jayashree Narayanan, M.S., Phone: 414-456-8094, E-mail: jay@mcw.edu

References

  • 1.Bohlen HG, Harper SL. Evidence of myogenic vascular control in the rat cerebral cortex. Cir Res. 1984;55:554–59. doi: 10.1161/01.res.55.4.554. [DOI] [PubMed] [Google Scholar]
  • 2.Harder DR. Comparison of electrical properties of middle cerebral and mesenteric artery in cat. Am J Physiol. 1980;239:C23–6. doi: 10.1152/ajpcell.1980.239.1.C23. [DOI] [PubMed] [Google Scholar]
  • 3.Harder DR, Gilbert R, Lombard JH. Vascular muscle cell depolarization and activation in renal arteries on elevation in transmural pressue. Am J Physiol. 1998;253:F778–81. doi: 10.1152/ajprenal.1987.253.4.F778. [DOI] [PubMed] [Google Scholar]
  • 4.McCarron JG, Osol G, Halpern W. Myogenic responses is independent of endothelium in rat pressurized posterior cerebral arteries. Blood Vessels. 1989;26:315–19. doi: 10.1159/000158780. [DOI] [PubMed] [Google Scholar]
  • 5.Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res. 2000;87:840–4. doi: 10.1161/01.res.87.10.840. [DOI] [PubMed] [Google Scholar]
  • 6.Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase. Role in cardiovascular biology and disease. Circ Res. 2000a;86:494–501. doi: 10.1161/01.res.86.5.494. [DOI] [PubMed] [Google Scholar]
  • 7.Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol. 2000b;20:2175–83. doi: 10.1161/01.atv.20.10.2175. [DOI] [PubMed] [Google Scholar]
  • 8.Wolin MS. Interaction of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol. 2000;20:1430–42. doi: 10.1161/01.atv.20.6.1430. [DOI] [PubMed] [Google Scholar]
  • 9.Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull. 1993;49:481–93. doi: 10.1093/oxfordjournals.bmb.a072625. [DOI] [PubMed] [Google Scholar]
  • 10.Cosentino F, Sill JC, Katusic ZS. Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension. 1994;23:229–35. doi: 10.1161/01.hyp.23.2.229. [DOI] [PubMed] [Google Scholar]
  • 11.Wei EP, Kontos HA, Beckman JS. Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide and peroxynitrite. Am J Physiol. 1996;271:H1262–6. doi: 10.1152/ajpheart.1996.271.3.H1262. [DOI] [PubMed] [Google Scholar]
  • 12.Leffler CW, Busija DW, Armstead WM, Mirro R. H2O2 effect on cerebral prostanoids and pial arteriolar diameter in piglets. Am J Physiol. 1990;258:H1382–7. doi: 10.1152/ajpheart.1990.258.5.H1382. [DOI] [PubMed] [Google Scholar]
  • 13.Wei EP, Kontos HA. H2O2 and endothelium-dependent cerebral arteriolar dilation. Implications for the identity of endothelium-derived relaxing factor generated by acetylcholine. Hypertension. 1990;16:162–9. doi: 10.1161/01.hyp.16.2.162. [DOI] [PubMed] [Google Scholar]
  • 14.Sobey CG, Heistad DD, Faraci FM. Potassium channels mediate dilatation of cerebral arterioles in response to arachidonate. Am J Physiol. 1998;275:H1606–12. doi: 10.1152/ajpheart.1998.275.5.H1606. [DOI] [PubMed] [Google Scholar]
  • 15.Sobey CG, Heistad DD, Faraci FM. Mechanisms of bradykinin-induced cerebral vasodilatation in rats. Evidence that reactive oxygen species activate K+ channels. Stroke. 1997;28:2290–5. doi: 10.1161/01.str.28.11.2290. [DOI] [PubMed] [Google Scholar]
  • 16.Iida Y, Katusic ZS. Mechanisms of cerebral arterial relaxations to hydrogen peroxide. Stroke. 2000;31:2224–30. doi: 10.1161/01.str.31.9.2224. [DOI] [PubMed] [Google Scholar]
  • 17.Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes RP, Busse R. Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is functionally significant source of reactive oxygen species in coronary arteries. Circ Res. 2001;88:44–51. doi: 10.1161/01.res.88.1.44. [DOI] [PubMed] [Google Scholar]
  • 18.Kojda G, Harrison D. Interaction between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res. 1999;43:562–71. doi: 10.1016/s0008-6363(99)00169-8. [DOI] [PubMed] [Google Scholar]
  • 19.Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268:C799–822. doi: 10.1152/ajpcell.1995.268.4.C799. [DOI] [PubMed] [Google Scholar]
  • 20.Trieschmann U, Isenberg G. Ca2+ -activated K+ channels contribute to the resting potential of vascular myocytes. Ca2+-sencitivity is increased by intracellular Mg2+-ions. Pflugers Archv. 1989;414:S183–84. doi: 10.1007/BF00582296. [DOI] [PubMed] [Google Scholar]
  • 21.Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science Wash DC. 1992;256:532–35. doi: 10.1126/science.1373909. [DOI] [PubMed] [Google Scholar]
  • 22.Marshal JJ, Kontos HA. Endothelium-derived relaxing factor: A prospective from in vivo data. Hypertension. 1990;16:371–86. doi: 10.1161/01.hyp.16.4.371. [DOI] [PubMed] [Google Scholar]
  • 23.Gebremedhin D, Lange AR, Narayanan J, Aebly MR, Jacobs ER, Harder DR. Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current. J Physiol. 1998;507:771–81. doi: 10.1111/j.1469-7793.1998.771bs.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Nelson MT, Conway MA, Knot HJ, Brayden JE. Chloride channel blockers inhibit myogenic tone in rat cerebral arteries. J Physiol. 1997;502:259–64. doi: 10.1111/j.1469-7793.1997.259bk.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Berzezinska AK, Gebremedhin D, Chilian WM, Kalyanaraman B, Elliott SJ. Peroinitrite inhibits large conductance Ca2+-activated K+ channels in rat cerebral arterial muscle cells. Am J Physiol. 2000;278:H1883–90. doi: 10.1152/ajpheart.2000.278.6.H1883. [DOI] [PubMed] [Google Scholar]
  • 26.Bychkov R, Pieper K, Ried C, Milosheva M, Bychkov E, Luft FC, Haller H. Hydrogen peroxide, potassium currents and membrane potential in human endothelial cells. Circulation. 1999;99:1719–25. doi: 10.1161/01.cir.99.13.1719. [DOI] [PubMed] [Google Scholar]
  • 27.Bychkov R, Gollasch M, Stienke T, Ried C, Luft FC, Haller H. Calcium-activated potassium channels and nitrate-induced vasodilation in human coronary arteries. J Pharmacol Exp Ther. 1998;285:293–98. [PubMed] [Google Scholar]
  • 28.Barlow RS, El-mowafey AM, White RE. H2O2 opens BKCa channels via the PLA2-arachidonic acid signaling cascade in coronary artery smooth muscle. Am J Physiol. 2000;279:H475–83. doi: 10.1152/ajpheart.2000.279.2.H475. [DOI] [PubMed] [Google Scholar]
  • 29.Barlow RS, White RE. Hydrogen peroxide relaxes porcine coronary arteries by stimulating BkCa channel activity. Am J Physiol. 1998;275:H1283–89. doi: 10.1152/ajpheart.1998.275.4.H1283. [DOI] [PubMed] [Google Scholar]
  • 30.Hayabuchi Y, Nakaya Y, Matsuoka S, Kuroda Y. Hydrogen peroxide-induced vascular relaxation in porcine coronary arteries is mediated by Ca2+-activated K+ channels. Am J Physiol. 1998;13:9–17. doi: 10.1007/BF02750638. [DOI] [PubMed] [Google Scholar]
  • 31.Metoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J ClinInvest. 2000;106:1521–30. doi: 10.1172/JCI10506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Graier WF, Hoebel BG, Paltauf-Doburzynska J, Kostner GM. Effect of superoxide anions on endothelial Ca2+ signaling pathways. Arteriosc Thromb Vasc Biol. 1998;18:1470–79. doi: 10.1161/01.atv.18.9.1470. [DOI] [PubMed] [Google Scholar]
  • 33.Wolin MS. Interaction of oxidants with vascular signaling systems. Arterioscle Thromb Vasc Biol. 2000;20:1430–42. doi: 10.1161/01.atv.20.6.1430. [DOI] [PubMed] [Google Scholar]
  • 34.Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, et al. Role of NADPH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension. 1998;32:4888–95. doi: 10.1161/01.hyp.32.3.488. [DOI] [PubMed] [Google Scholar]
  • 35.Servitja JM, Masgrau R, Pardo R, Sarri E, Picatoste F. Effects of oxidative stress on phospholipid signaling in rat cultured astrocytes and brain slices. J Neurochem. 2000;75:788–794. doi: 10.1046/j.1471-4159.2000.0750788.x. [DOI] [PubMed] [Google Scholar]
  • 36.Gopalakrishna R, Jaken S. Protein kinase C signaling and oxidative stress. Free Radic Biol Med. 2000;28:1349–61. doi: 10.1016/s0891-5849(00)00221-5. [DOI] [PubMed] [Google Scholar]
  • 37.Shubert R, Noack T, Serebrykov VN. Protein kinase C reduces KCa current of rat tail artery smooth muscle cells. Am J Physiol. 1999;276:C648–58. doi: 10.1152/ajpcell.1999.276.3.C648. [DOI] [PubMed] [Google Scholar]
  • 38.Shipston MJ, Armstrong DL. Activation of protein kinase C inhibits calcium-activated potassium channels in rat pituitary tumor cells. J Physiol. 1996;493:665–72. doi: 10.1113/jphysiol.1996.sp021413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Zagorac D, Yamaura K, Zhang C, Roman RJ, Harder DR. The effect of superoxide anion on autoregulation of cerebral blood flow. Stroke. 2005;36:2589–94. doi: 10.1161/01.STR.0000189997.84161.95. [DOI] [PubMed] [Google Scholar]
  • 40.Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes RP, Busse R. Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is functionally significant source of reactive oxygen species in coronary arteries. Cir Res. 2001;88:44–51. doi: 10.1161/01.res.88.1.44. [DOI] [PubMed] [Google Scholar]
  • 41.Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, et al. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res. 2000;87:60–5. doi: 10.1161/01.res.87.1.60. [DOI] [PubMed] [Google Scholar]
  • 42.Kauser K, Clark JE, Masters BS, Ortiz de Montellano PR, Ma YH, Harder DR, Roman RJ. Inhibitors of cytochrome P450 attenuate the myogenic response of dog renal arcuate arteries. Circ Res. 1991;68:1154–63. doi: 10.1161/01.res.68.4.1154. [DOI] [PubMed] [Google Scholar]
  • 43.Boderick JP, Brott T, Tomsick T, Miller R, Huster G. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg. 1993;78:188–91. doi: 10.3171/jns.1993.78.2.0188. [DOI] [PubMed] [Google Scholar]
  • 44.Hutter BO, Kreitschmann-Andermahr I, Gilsbach JM. Health-related quality of life after aneurismal subarachnoid hemorrhage: impacts of bleeding severity, computerized tomography findings, surgery, vasospasm and neurological grade. J Neurosurg. 2001;94:241–51. doi: 10.3171/jns.2001.94.2.0241. [DOI] [PubMed] [Google Scholar]
  • 45.Asano T, Sasaki T, Koide T, Takakura K, Sano K. Experimental evaluation of the beneficial effect of an antioxidant on cerebral vasospasm: the effect of an antioxidant on cerebral vasospasm. Neurol Res. 1984;6:49–53. doi: 10.1080/01616412.1984.11739663. [DOI] [PubMed] [Google Scholar]
  • 46.Mori T, Nagata K, Ishida T, Ohami H, Asano T. Superoxide anions in the pathogenesis of talc-induced cerebral vasocontraction. Neuropathol Appl Neurobiol. 1995;21:378–85. doi: 10.1111/j.1365-2990.1995.tb01074.x. [DOI] [PubMed] [Google Scholar]
  • 47.MacDonald RL, Weir BKA. A review of hemoglobin and the pathogenesis of chronic cerebral vasospasm. Stroke. 1991;22:971–82. doi: 10.1161/01.str.22.8.971. [DOI] [PubMed] [Google Scholar]
  • 48.Haber F, Weiss J. The catalytic decomposition of hydrogen peroxidase by iron salts. Proc R Soc Lond A. 1934;147:332–51. [Google Scholar]
  • 49.Fenton HJH. Oxidation of tartaric acid in the presence of ion. J Chem Soc. 1894;23:899–10. [Google Scholar]
  • 50.Shishido T, Suzuki R, Qian L, Hirakawa K. The role of superoxide anions in the pathogenesis of cerebral vasospasm. Stroke. 1994;25:864–68. doi: 10.1161/01.str.25.4.864. [DOI] [PubMed] [Google Scholar]
  • 51.Fadel MM, Foley PL, Kassell NF, Lee KS. Histidine attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage. Surg Neurol. 1995;43:52–8. doi: 10.1016/0090-3019(95)80038-i. [DOI] [PubMed] [Google Scholar]
  • 52.Watanabe T, Nishiyama M, Hori T, Asano T, Shimizu T, Masayasu H. Ebselen ameliorates delayed cerebral vasospasm in a canine two-hemorrhage model. Neurol Res. 1997;19:563–65. doi: 10.1080/01616412.1997.11740859. [DOI] [PubMed] [Google Scholar]
  • 53.Germano A, Imperatore C, D’Avella D, Costa G, Tomasello F. Antivasospastic and brain-protective effects of a hydroxyl radical scavenger (AVS) after experimental subarachnoid hemorrhage. J Neurosurg. 1998;88:1075–81. doi: 10.3171/jns.1998.88.6.1075. [DOI] [PubMed] [Google Scholar]
  • 54.Saito I, Asano T, Sano K, Takakura K, Abe H, Yoshimoto T, et al. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery. 1998;42:269–77. doi: 10.1097/00006123-199802000-00038. [DOI] [PubMed] [Google Scholar]
  • 55.Arthur AS, Fergus AH, Lanzino G, Mathys J, Kassell NF, Lee KS. Systemic administration of the iron chelator deferiprone attenuates subarachnoid hemorrhage-induced cerebral vasospasm in the rabbit. Neurosurgery. 1997;41:1385–91. doi: 10.1097/00006123-199712000-00028. [DOI] [PubMed] [Google Scholar]
  • 56.Horky LL, Pluta RM, Boock RJ, Oldfield EH. Role of ferrous iron chelator 2,2′-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg. 1998;88:298–303. doi: 10.3171/jns.1998.88.2.0298. [DOI] [PubMed] [Google Scholar]
  • 57.Potts MB, Koh SE, Whetstone WD, et al. Traumatic injury to the immature brain: potential therapeutic target. Neuron RX. 2006;3:143–53. doi: 10.1016/j.nurx.2006.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES